Comparing the current results to its competitors, Firefly Neuroscience Inc reported Revenue increase in the 2 quarter 2026 by 71.91 % year on year. The sales growth was above Firefly Neuroscience Inc 's competitors' average revenue growth of 9.72 %, achieved in the same quarter.
Firefly Neuroscience Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 2.88 %
Firefly Neuroscience Inc 's Comment on Competition and Industry Peers
The company faces competition from third parties holding numerous patents in the U.S. and other jurisdictions. Competitors may develop systems, devices, or methods outside the scope of the company's patents, which could affect the company's ability to prevent commercialization of its patented inventions. The company's commercial success relies on obtaining, maintaining, defending, and enforcing its patent claims, as well as avoiding infringement of third-party intellectual property rights.
Due to outstanding performance in Overall company, revenue grew by 71.91 % Firefly Neuroscience Inc improved its market share, to approximately 0.01 %.
January 24, 2025
In a groundbreaking development poised to transform the landscape of drug development and neuropsychiatric care, Firefly Neuroscience has announced a series of publications demonstrating the efficacy of its advanced EEG analytics platform. Highlighting a growing body of clinical evidence, these publications emphasize the potential of Firefly s FDA-cleared Brain Network Analytics (BNA) platform to offer measures of drug efficacy and cognitive change. This innovation marks a significant step forward in how brain health is understood and treated. Revolutionizing Drug DevelopmentTraditional methods of assessing drug efficacy in the treatment of neuropsychiatric conditions often rely on subjective measures and s...
October 16, 2024
In a significant development within the biotechnology sector, Firefly Neuroscience has announced a collaboration with Bright Minds Biosciences to analyze data derived from a successful Phase 1 clinical study. This partnership aims to utilize Firefly’s innovative artificial intelligence (AI) technology, specifically its FDA-cleared Brain Network Assessment (BNA) platform, to enhance understanding of neurophysiological responses in study participants.As part of the Phase 1 study, participants were equipped with electroencephalogram (EEG) headsets developed by Zeto, a partner of Firefly. This technology enabled the collection of critical brain activity data, which investigators believe could yield insights in...
Adobe Inc.s business model centers on delivering a diverse range of software and services that cater to digital media creation, marketing, and document management needs. Their flagship products, including Photoshop, Illustrator, and Acrobat, empower both professionals and casual users, while their cloud-based offerings like Creative Cloud and Document Cloud facilitate seamless collaboration and accessibility across devices. The company primarily generates revenue through subscription licensing for its software, along with enterprise solutions and document services.
Gartner Inc. operates a business model focused on delivering research and advisory services aimed at helping organizations improve their performance and strategic decision-making. Their revenue is primarily generated through subscription-based access to a comprehensive suite of research reports, expert analyses, and consulting services tailored to various industries.
Oracle Corporations business model focuses on providing enterprise software solutions and cloud services. It generates revenue through software licenses, cloud subscriptions, and consulting and support services, addressing data management needs and the increasing demand for cloud technologies.
Sources:
Firefly Neuroscience Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Firefly Neuroscience Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
